Deborah J. Andrews
Directeur/Membre du Conseil chez LINEAGE CELL THERAPEUTICS, INC.
Fortune : 17 292 $ au 30/04/2024
Profil
Deborah J.
Andrews is an Independent Director at Lineage Cell Therapeutics, Inc. since 2014.
She was the Chief Financial Officer at STAAR Surgical Co. from 2017 to 2020.
Prior to that, she worked as an Auditor at KPMG Peat Marwick LLP from 1991 to 1994, and as an Internal Auditor at Bourns, Inc. from 1994 to 1995.
She also served as the Vice President-Finance at STAAR Surgical AG in 2001.
Andrews completed her undergraduate degree from California State University-San Bernardino.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/07/2023 | 15 578 ( 0,01% ) | 17 292 $ | 30/04/2024 |
Postes actifs de Deborah J. Andrews
| Sociétés | Poste | Début |
|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/04/2014 |
Anciens postes connus de Deborah J. Andrews
| Sociétés | Poste | Fin |
|---|---|---|
| STAAR SURGICAL COMPANY | Directeur Financier/CFO | 06/07/2020 |
STAAR Surgical AG
 STAAR Surgical AG Medical SpecialtiesHealth Technology Part of STAAR Surgical Co., STAAR Surgical AG is a Swiss company that designs, develops, manufactures, and markets implantable lenses for the eye with companion delivery systems. The company is based in Nidau, Switzerland. The company's lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The company offers refractive solutions for myopia, hyperopia, and astigmatism, as well as cataract solutions. The company's innovative products are designed to conveniently deliver high-quality intraocular lenses through a small incision in a predictable, efficient manner. The company has sold over 2 million collamer lenses worldwide and has over 900 employees, marketing lenses in over 75 countries. | Directeur Financier/CFO | 01/01/2001 |
Bourns, Inc.
 Bourns, Inc. Electrical ProductsProducer Manufacturing Bourns, Inc. manufactures and distributes electronic components. The firm products include automotive, circuit protection, outside plant products, connectors, diodes, encoders and pro lighting. It serves a broad range of markets, including automotive, industrial, consumer, communications, non-critical life support medical, audio, and various other market segments. The company was founded by Marlan Bourns and Rosemary Bourns in 1947 and is headquartered in Riverside, CA. | Comptroller/Controller/Auditor | 01/01/1995 |
| KPMG Peat Marwick LLP | Comptroller/Controller/Auditor | 01/01/1994 |
Formation de Deborah J. Andrews
| California State University-San Bernardino | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| STAAR SURGICAL COMPANY | Health Technology |
| LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| KPMG Peat Marwick LLP | Commercial Services |
Bourns, Inc.
Bourns, Inc. Electrical ProductsProducer Manufacturing Bourns, Inc. manufactures and distributes electronic components. The firm products include automotive, circuit protection, outside plant products, connectors, diodes, encoders and pro lighting. It serves a broad range of markets, including automotive, industrial, consumer, communications, non-critical life support medical, audio, and various other market segments. The company was founded by Marlan Bourns and Rosemary Bourns in 1947 and is headquartered in Riverside, CA. | Producer Manufacturing |
STAAR Surgical AG
STAAR Surgical AG Medical SpecialtiesHealth Technology Part of STAAR Surgical Co., STAAR Surgical AG is a Swiss company that designs, develops, manufactures, and markets implantable lenses for the eye with companion delivery systems. The company is based in Nidau, Switzerland. The company's lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The company offers refractive solutions for myopia, hyperopia, and astigmatism, as well as cataract solutions. The company's innovative products are designed to conveniently deliver high-quality intraocular lenses through a small incision in a predictable, efficient manner. The company has sold over 2 million collamer lenses worldwide and has over 900 employees, marketing lenses in over 75 countries. | Health Technology |